Construction And Real Estate Tenders

See procurement description
Doc Title: Pharmaceutical products
Contract Type: Supplies

Section 130a paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be supplied at the expense of the statutory health insurance companies. With regard to the relevant legal regulations for the award of public contracts, seeet a regular process of active ingredient-related, formal award procedures takes place in accordance with the regulations of Part 4 of the GWB by DAK-Gesundheit. For medicines to be specified by the bidder in Annex 2 to the contract in relation to the above. Active ingredient, Follitropin beta, ATC G03GA06, intends the DAK-Gesundheit to conclude drug discount agreements with as many interested pharmaceutical companies as possible until new drug discount agreements come into force. A discount contract in the form of an approval model for the above-mentioned. The active ingredient comes into force for the first time on November 1st, 2023 and ends on October 31st, 202025. Regardless, it ends automatically when the exclusive contract comes into force.
Doc Title: Pharmaceutical products
Contract Type: Supplies

See procurement description
Doc Title: Pharmaceutical products
Contract Type: Supplies

Harstad Municipality and Hålogalandsrådet (later called the contracting authorities) need consultancy services for the contracting authority's work on strengthening the regional centre's attractiveness for businesses, the town, and as a place to live. The consultancy services must be able to contribute with project and process management, business contact and network, development work, review work, and writing applications within areas, but not limited to transport and business in the region.
Doc Title: Project management consultancy services
Contract Type: Services

Section 130a paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be supplied at the expense of the statutory health insurance companies. With regard to the relevant legal regulations for the award of public contracts, seeet a regular process of active ingredient-related, formal award procedures takes place in accordance with the regulations of Part 4 of the GWB by DAK-Gesundheit. For medicines to be specified by the bidder in Annex 2 to the contract in relation to the above. The active ingredient, raltegravir, ATC J05AX08, intends to use the DAK-Gesand to conclude drug discount agreements with as many interested pharmaceutical companies as possible until new drug discount agreements come into force. A discount contract in the form of an approval model for the above-mentioned. The active ingredient comes into force for the first time on November 1st, 2023 and ends on October 31st, 2025. EIrrespective of this, it ends automatically when the exclusive contract comes into force.
Doc Title: Pharmaceutical products
Contract Type: Supplies

See procurement description
Doc Title: Pharmaceutical products
Contract Type: Supplies

Section 130a paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be supplied at the expense of the statutory health insurance companies. With regard to the relevant legal regulations for the award of public contracts, seeet a regular process of active ingredient-related, formal award procedures takes place in accordance with the regulations of Part 4 of the GWB by DAK-Gesundheit. For medicines to be specified by the bidder in Annex 2 to the contract in relation to the above. Active ingredient, iron (parenteral preparations), ATC B03AC01, B03AC02, B03AC06, B03AC07, DAK-Gesundheit intends to conclude drug discount agreements with as many interested pharmaceutical companies as possible until new drug discount agreements come into force. A discount contract in the form of an approval model for the above-mentioned. Active ingredient appears for the first time am November 1st, 2023 and ends on October 31st, 2024 (plus extension option 1x12 months). Regardless, it ends automatically when the exclusive contract comes into force.
Doc Title: Pharmaceutical products
Contract Type: Supplies

This procurement has been transferred to Varsinais-Suomen welfare area pursuant to Section 4 of the Social Security Organization Act and Social Security Implementation Act (616/2021). A dynamic journalist sleighall candidates who have submitted an application for participation and meet the requirements stated in this request for participation will be selected.
Varsinais-Suomen welfare area makes a decision regarding the purchase. The customer will later make an agreement with the Service Providers selected in the dynamic supplier registerown contract per living unit.
The procurement is divided into four parts:
1. Enhanced service housing for the elderly for Finnish speakers
2. Enhanced service housing for the elderly for Swedish speakers
3. Demanding enhanced service housing for memory sufferers for Finnish speakers
4. Demanding muienhanced service housing for sick people for Swedish speakers
More information can be found in the request for participation and in attachments 1-9.
The contract is concluded until August 31, 2026 at most, after which the contract can be extended by the customer's decision with two (2) one (1) year options for the period of September 1, 2026 - August 31.2027 and 1/9/2027 - 31/8/2028.
The procurement procedure (dynamic supplier register) made possible by Chapter 12 of the Act on Public Procurement and Right-of-Use Agreements (1397/2016, hereinafter ``Procurement Act') is applied to the procurement (dynamic supplier register), a more detailed description of which is presented...

Section 130a paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be supplied at the expense of the statutory health insurance companies. With regard to the relevant legal regulations for the award of public contracts, seeet a regular process of active ingredient-related, formal award procedures takes place in accordance with the regulations of Part 4 of the GWB by DAK-Gesundheit. For medicines to be specified by the bidder in Annex 2 to the contract in relation to the above. Active ingredient, formoterol, beclometasone, glycopyrronium, ATC R03AL09, DAK-Gesundheit intends to conclude drug discount agreements with as many interested pharmaceutical companies as possible until new drug discount agreements come into force. A discount contract in the form of an approval model for the above-mentioned. The active ingredient comes into effect for the first time on November 1st, 2023t and ends on October 31, 2025. Regardless, it ends automatically when the exclusive contract comes into force.
Doc Title: Pharmaceutical products
Contract Type: Supplies

Section 130a paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be supplied at the expense of the statutory health insurance companies. With regard to the relevant legal regulations for the award of public contracts, seeet a regular process of active ingredient-related, formal award procedures takes place in accordance with the regulations of Part 4 of the GWB by DAK-Gesundheit. For medicines to be specified by the bidder in Annex 2 to the contract in relation to the above. Active ingredient, tiotropium bromide (exclusively in the dosagesform solution for inhalation), ATC R03BB04, DAK-Gesundheit intends to conclude drug discount agreements with as many interested pharmaceutical companies as possible until new drug discount agreements come into force. A discount contract in the form of an approval model for the above-mentioned. active ingredientf comes into force for the first time on November 1st, 2023 and ends on October 31st, 2025. Regardless, it ends automatically when the exclusive contract comes into force.
Doc Title: Pharmaceutical products
Contract Type: Supplies